Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
07/18/2025 | CALL | $0.50 | 87 | +40 | +85.11% |
02/21/2025 | CALL | $1.50 | 104 | +38 | +57.58% |
07/18/2025 | CALL | $1.50 | 32 | +30 | +1,500.00% |
01/17/2025 | CALL | $1.50 | 577 | +19 | +3.41% |
04/17/2025 | CALL | $1.00 | 24,478 | +15 | +0.06% |
01/17/2025 | CALL | $1.00 | 1,348 | +5 | +0.37% |
07/18/2025 | PUT | $1.50 | 0 | 0 | |
07/18/2025 | PUT | $2.00 | 0 | 0 | |
07/18/2025 | PUT | $2.50 | 0 | 0 | |
07/18/2025 | PUT | $5.00 | 0 | 0 | |
07/18/2025 | PUT | $7.50 | 0 | 0 | |
01/17/2025 | CALL | $0.50 | 318 | -300 | -48.54% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Trust for Advised Port-Opportunity Trust | 3.37% | 8.5M | 9.86M |
Vanguard Total Stock Market Index Fund | 1.15% | 2.9M | 3.37M |
iShares Russell 2000 ETF | 0.89% | 2.24M | 2.6M |
Vanguard Extended Market Index Fund | 0.51% | 1.28M | 1.48M |
Fidelity Small Cap Index Fund | 0.33% | 823.62k | 955.39k |
iShares NASDAQ Biotechnology ETF | 0.31% | 786.93k | 912.84k |
iShares Russell 2000 Growth ETF | 0.26% | 653.53k | 758.1k |
Fidelity Extended Market Index Fund | 0.20% | 509.54k | 591.06k |
Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 0.17% | 428.51k | 497.08k |
TIAA-CREF Funds-Equity Index Fund | 0.12% | 303.57k | 352.14k |
Precigen Soars: Biologics License Application Submission For PRGN-2012 Targets First FDA-Approved Recurrent Respiratory Papillomatosis Treatment
12/30 01:31 pm
Benzinga
Read more6 Analysts Assess Precigen: What You Need To Know
06/03 01:00 pm
Benzinga
Read moreWall Street Breakfast: The Week Ahead
06/02 06:49 am
Seeking Alpha
Read morePrecigen, Inc. (PGEN) Reports Q1 Loss, Misses Revenue Estimates
05/14 05:20 pm
Zacks Investment Research
Read moreAllogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates
05/13 05:10 pm
Zacks Investment Research
Read moreMonday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market Session
02/12 09:16 am
Benzinga
Read moreFisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
09/26 10:49 am
Benzinga
Read moreShould You Buy Precigen, Inc. (PGEN) After Golden Cross?
09/05 09:55 am
Zacks Investment Research
Read moreWhy Nordstrom Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
08/25 01:32 pm
Benzinga
Read moreHibbett, American Software, Ardelyx And Other Big Stocks Moving Higher On Friday
08/25 10:57 am
Benzinga
Read more10 Top Penny Stocks To Buy According To Insiders In August
08/17 12:16 pm
PennyStocks
Read moreCisco, Children's Place, LSI Industries And Other Big Stocks Moving Higher On Thursday
08/17 10:17 am
Benzinga
Read moreCano Health, Maxeon Solar Technologies, Velo3D And Other Big Stocks Moving Lower In Friday's Pre-Market Session
08/11 07:03 am
Benzinga
Read moreAlibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday
08/10 10:39 am
Benzinga
Read moreTango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Tops Revenue Estimates
08/07 08:15 am
Zacks Investment Research
Read moreFulcrum Therapeutics, Inc. (FULC) Reports Q2 Loss, Lags Revenue Estimates
08/03 08:15 am
Zacks Investment Research
Read moreMorgan Stanley, Charles Schwab, Bank of America, And Other Big Stocks Moving Higher On Tuesday
07/18 10:22 am
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
05/23 11:00 am
Benzinga
Read moreParatek Pharmaceuticals (PRTK) Reports Q1 Loss, Misses Revenue Estimates
05/09 05:45 pm
Zacks Investment Research
Read moreHeska (HSKA) Q1 Earnings and Revenues Lag Estimates
05/05 09:15 am
Zacks Investment Research
Read moreInsmed (INSM) Reports Q1 Loss, Tops Revenue Estimates
05/04 08:55 am
Zacks Investment Research
Read moreStrong Small-Cap Insider Buys: Q1 2023
04/26 12:15 am
Seeking Alpha
Read more5 Penny Stocks To Watch Today; Is It Time To Buy?
04/20 02:27 pm
PennyStocks
Read more2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years
03/17 06:59 am
The Motley Fool
Read moreHere's Why Precigen, Inc. (PGEN) Is a Great 'Buy the Bottom' Stock Now
03/14 09:55 am
Zacks Investment Research
Read more5 Penny Stocks To Buy According To Analysts, Targets Up To 952%
03/07 12:35 pm
PennyStocks
Read moreFate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates
02/28 06:15 pm
Zacks Investment Research
Read moreBioMarin Pharmaceutical (BMRN) Q4 Earnings Lag Estimates
02/27 06:35 pm
Zacks Investment Research
Read moreUltragenyx (RARE) Reports Q4 Loss, Tops Revenue Estimates
02/16 06:15 pm
Zacks Investment Research
Read more3 Penny Stocks To Buy According To Insider Bets Up To $25 Million
02/06 04:53 pm
PennyStocks
Read more$20 Million Bet On Precigen? Check Out These 4 Penny Stocks Insiders Are Buying
02/01 11:44 am
Benzinga
Read morePrecigen, Inc. (PGEN) Moves to Buy: Rationale Behind the Upgrade
01/27 01:00 pm
Zacks Investment Research
Read moreBenzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring, But Not Yet Talking About
01/26 04:56 pm
Benzinga
Read moreNasdaq Down Over 200 Points; AT&T Posts Upbeat Earnings
01/25 01:48 pm
Benzinga
Read moreUS Stocks Open Lower; Dow Dips 250 Points
01/25 11:11 am
Benzinga
Read more3 Penny Stocks That Could Make You Filthy Rich
01/25 08:30 am
The Motley Fool
Read moreIntuitive Surgical, Microsoft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
01/25 07:29 am
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
11/18 12:58 pm
Benzinga
Read morePrecigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates
11/09 07:35 pm
Zacks Investment Research
Read more